Heyholder
‹ Back to the disclosure you were reading

Cellid Co., Ltd. Lawsuit filed to invalidate issuance of 1,102,973 new common shares

Cellid Co., Ltd.· Litigation

AI summary · Not investment advice

Lee OO filed a suit seeking to invalidate the issuance of 1,102,973 new common shares allotted to third parties.

Key facts

Plaintiff/Applicant
Lee OO
Claim
1. Invalidate the issuance of 1,102,973 common shares allotted to Centrust Investment Partnership (686,498 shares) and SPE Partners Investment Partnership (416,475 shares) under board resolutions of September 22 and October 2, 2026. 2. The defendant bears the litigation costs.
Court
Seoul Central District Court
Filing date
Oct 25, 2026Date the plaintiff filed the complaint with the court
Company response
The company will appoint legal counsel and respond to the lawsuit in accordance with relevant laws and procedures.
Case
Invalidation of new share issuance
Case number
2026Gahap9808
Date confirmed
Nov 9, 2026Date the company received the complaint
Related disclosure
2026.09.22 Report on Material Matters (Decision on Rights Offering) / Small Public Offering (Third-Party Allotment)Later amended filings and the small public offering result report are also listed as related disclosures

Earlier Litigation filings from this company

Filings of the same type
FiledTitleKey figure · Note
26.11.05Litigation—
26.11.04[Amended] Litigation—
26.11.04[Amended] LitigationInjunction to prohibit new share issuance (2026Kahap21950)

Comments

No comments yet

Comments from shareholders will appear here.